tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GRI Stock Latest News

Promising Potential of GRI-0621 in IPF Treatment: A Buy Recommendation by Matthew Keller
RatingsPromising Potential of GRI-0621 in IPF Treatment: A Buy Recommendation by Matthew Keller
22d ago
GRI
GRI Bio Closes $8 Million Public Offering
PremiumCompany Announcements
GRI Bio Closes $8 Million Public Offering
26d ago
8K
GRI
GRI Bio Launches $6.7 Million Public Offering
PremiumCompany Announcements
GRI Bio Launches $6.7 Million Public Offering
26d ago
8K
GRI
GRI Bio prices 10.67M shares at 75c in public offering
PremiumThe Fly
GRI Bio prices 10.67M shares at 75c in public offering
27d ago
GRI
GRI Bio announces GRI-0621-IPF-02 trial met primary, secondary endpoints
PremiumThe Fly
GRI Bio announces GRI-0621-IPF-02 trial met primary, secondary endpoints
28d ago
GRI
GRI Bio Announces Positive Phase 2a Trial Results
PremiumCompany AnnouncementsGRI Bio Announces Positive Phase 2a Trial Results
28d ago
8K
GRI
GRI Bio Reports Positive Phase 2a Trial Results
Premium
Company Announcements
GRI Bio Reports Positive Phase 2a Trial Results
1M ago
8K
GRI
GRI Bio files to sell 5.13M shares of common stock, warrants
Premium
The Fly
GRI Bio files to sell 5.13M shares of common stock, warrants
1M ago
GRI
GRI Bio Faces Nasdaq Non-Compliance Notice
PremiumCompany Announcements
GRI Bio Faces Nasdaq Non-Compliance Notice
1M ago
8K
GRI
Promising Interim Results and Strong Financial Position Justify Buy Rating for GRI Bio
PremiumRatings
Promising Interim Results and Strong Financial Position Justify Buy Rating for GRI Bio
2M ago
GRI
GRI Bio reports six-week lung function data in Phase 2a study of GRI-0621
PremiumThe Fly
GRI Bio reports six-week lung function data in Phase 2a study of GRI-0621
4M ago
GRI
Gri Bio Reports Q2 Loss Amid Clinical Advancements
PremiumCompany Announcements
Gri Bio Reports Q2 Loss Amid Clinical Advancements
5M ago
GRI
GRI Bio Advances with Positive GRI-0621 Data
PremiumCompany AnnouncementsGRI Bio Advances with Positive GRI-0621 Data
5M ago
8K
GRI
GRI Bio Stockholders Approve Equity Plan Amendment
Premium
Company Announcements
GRI Bio Stockholders Approve Equity Plan Amendment
5M ago
8K
GRI
Gri Bio, Inc. (GRI) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Gri Bio, Inc. (GRI) Q2 Earnings Cheat Sheet
5M ago
GRI
Buy Recommendation for GRI Bio: Promising Phase 2a Study of GRI-0621 in IPF with Strong Biomarker Strategy
PremiumRatings
Buy Recommendation for GRI Bio: Promising Phase 2a Study of GRI-0621 in IPF with Strong Biomarker Strategy
5M ago
GRI
GRI Bio Announces Positive Interim Data for GRI-0621
PremiumCompany Announcements
GRI Bio Announces Positive Interim Data for GRI-0621
5M ago
8K
GRI
GRI Bio reports 6-week interim biomarker results from Phase 2a study in IPF
PremiumThe Fly
GRI Bio reports 6-week interim biomarker results from Phase 2a study in IPF
5M ago
GRI
Optimistic Buy Rating for GRI Bio Amidst Promising Clinical Trial Developments and Strategic Insights
PremiumRatings
Optimistic Buy Rating for GRI Bio Amidst Promising Clinical Trial Developments and Strategic Insights
6M ago
GRI
GRI Bio completes enrollment in Phase 2a study of GRI-0621
PremiumThe FlyGRI Bio completes enrollment in Phase 2a study of GRI-0621
6M ago
GRI
GRI Bio Announces Positive Interim Phase 2a Results
Premium
Company Announcements
GRI Bio Announces Positive Interim Phase 2a Results
7M ago
8K
GRI
GRI Bio reports 6-week interim safety data from Phase 2a study of GRI-0621
Premium
The Fly
GRI Bio reports 6-week interim safety data from Phase 2a study of GRI-0621
7M ago
GRI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >